These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 9475264

  • 1. No cross-tolerance between S-nitrosocaptopril and nitroglycerin in dog coronary arteries in vivo.
    Takaoka A, Nakae I, Takahashi M, Matsumoto T, Liu Q, Mitsunami K, Kinoshita M.
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):231-9. PubMed ID: 9475264
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effects of S-nitrosocaptopril on canine coronary circulation.
    Nakae I, Takahashi M, Kinoshita T, Matsumoto T, Kinoshita M.
    J Pharmacol Exp Ther; 1995 Jul; 274(1):40-6. PubMed ID: 7616425
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of nitroglycerin on pacing-induced changes in myocardial oxygen consumption and metabolic coronary vasodilation in patients with coronary artery disease.
    Kal JE, Vergroesen I, van Wezel HB.
    Anesth Analg; 1999 Feb; 88(2):271-8. PubMed ID: 9972740
    [Abstract] [Full Text] [Related]

  • 10. Sustained antiplatelet properties of nitroglycerin during hemodynamic tolerance in rats.
    Booth BP, Jacob S, Bauer JA, Fung HL.
    J Cardiovasc Pharmacol; 1996 Sep; 28(3):432-8. PubMed ID: 8877591
    [Abstract] [Full Text] [Related]

  • 11. Differential inhibition of platelet aggregation and calcium mobilization by nitroglycerin and stabilized nitric oxide.
    Amano M, Takahashi M, Kosaka T, Kinoshita M.
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):860-6. PubMed ID: 7898066
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Two possible mechanisms underlying nitrate tolerance in monkey coronary arteries.
    Omura T, Matsumoto T, Nakae I, Takahashi M, Kinoshita M.
    Clin Exp Pharmacol Physiol; 2001 Apr; 28(4):259-65. PubMed ID: 11251637
    [Abstract] [Full Text] [Related]

  • 16. Long-term nitroglycerin treatment is associated with supersensitivity to vasoconstrictors in men with stable coronary artery disease: prevention by concomitant treatment with captopril.
    Heitzer T, Just H, Brockhoff C, Meinertz T, Olschewski M, Münzel T.
    J Am Coll Cardiol; 1998 Jan; 31(1):83-8. PubMed ID: 9426022
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Contrasting effects of blockade of nitric oxide formation on resistance and conductance coronary vessels in conscious dogs.
    Parent R, Hamdad N, Ming Z, Lavallée M.
    Cardiovasc Res; 1996 Apr; 31(4):555-67. PubMed ID: 8689647
    [Abstract] [Full Text] [Related]

  • 19. Vagal nerve stimulation releases vasoactive intestinal peptide which significantly increases coronary artery blood flow.
    Feliciano L, Henning RJ.
    Cardiovasc Res; 1998 Oct; 40(1):45-55. PubMed ID: 9876316
    [Abstract] [Full Text] [Related]

  • 20. N-acetylcysteine attenuates nitroglycerin tolerance in patients with angina pectoris and normal left ventricular function.
    Pizzulli L, Hagendorff A, Zirbes M, Jung W, Lüderitz B.
    Am J Cardiol; 1997 Jan 01; 79(1):28-33. PubMed ID: 9024731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.